Researchers in the CU Department of Biomedical Informatics have identified a potential new immune checkpoint receptor that could lead to treatments for diseases such as lung and bowel cancer and autoimmune conditions including IBD.
Home News CU Anschutz Researchers Identify Unique Cell Receptor, Potential for New Therapies back to News
CU Anschutz Researchers Identify Unique Cell Receptor, Potential for New Therapies
Written by CU Anschutz News on June 30, 2023
Topics: Press Coverage